Table 3.
Comparisons of outcomes between different pharmacologic treatments
| Reference | Interventions | Hot flashes | Mood | Quality of life |
Patient preference |
Blood Pressure |
Additional side effectsa |
Time to hot flash improvement |
|---|---|---|---|---|---|---|---|---|
| Boekhout et al. [33] | Venlafaxine 75 mg or clonidine 0.1 mg daily | ↔ | Clonidine: ↑ anxiety Venlafaxine: ↑ depression |
N/A | ↔ | ↔ | Venlafaxine: ↓ appetite | Favors venlafaxine (effect in 1-2 weeks) over clonidine (>4 weeks) |
| Bordeleau et al. [34] | Venlafaxine 75 mg or gabapentin 900 mg daily | ↔ | Venlafaxine (vs. gabapentin): ↓ negative mood | ↔ | Venlafaxine preferred | N/A | Venlafaxine: ↓ appetite, ↑nausea and constipation Gabapentin: ↑dizziness, ↑appetite |
↔ |
| Buijs et al. [35] | Venlafaxine 75 mg or clonidine 0.1 mg daily | ↔ | Venlafaxine: ↓ depression | ↔ | ↔ | Clonidine: ↓ 5 mmHg systolic ↓ 3 mmHg diastolic |
Venlafaxine: ↓appetite, ↑nausea and constipation, ↑study withdrawal Clonidine: ↑pain, ↑itching |
↔ |
| Loibl et al. [36] | Venlafaxine 75 mg daily or clonidine 0.15 mg daily | Favors venlafaxine | N/A | N/A | N/A | N/A | Venlafaxine: ↑nausea | Favors venlafaxine |
↔ no difference among groups, ↑ increased, ↓, decreased, N/A not assessed
Only outcomes that were statistically significantly different among hot flash treatment groups are presented